Pleiotropic role of IGF-I in obesity hypoventilation syndrome

Growth Hormone and IGF Research

Volumn 20, Issue 2, 2010, Pages 127-133

  Monneret, Denis ^a,b   Borel, Jean Christian ^a,b   Pepin, Jean Louis ^a,b   Tamisier, Renaud ^a,b   Arnol, Nathalie ^a,b   Levy, Patrick ^a,b   Faure, Patrice ^a,b  

^a INSERM   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Hypercapnia; Insulin like growth factor I; Obesity hypoventilation syndrome; Somatotropic axis; Triglycerides

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BREATHING MUSCLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION TEST; FEMALE; FORCED VITAL CAPACITY; HUMAN; HYPERCAPNIA; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; MALE; MUSCLE WEAKNESS; OBESITY HYPOVENTILATION SYNDROME; PLEIOTROPY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY DRIVE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERCAPNIA; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY HYPOVENTILATION SYNDROME; OBESITY, MORBID; POLYSOMNOGRAPHY; RESPIRATION; TRIGLYCERIDES; YOUNG ADULT;

EID: 77949657541     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.11.004     Document Type: Article

References (44)

1. Olson A.L., Zwillich C. The obesity hypoventilation syndrome. Am. J. Med. 2005, 118:948-956.
2. Nowbar S., Burkart K.M., Gonzales R., Fedorowicz A., Gozansky W.S., Gaudio J.C., Taylor M.R., Zwillich C.W. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am. J. Med. 2004, 116:1-7.
3. Berg G., Delaive K., Manfreda J., Walld R., Kryger M.H. The use of health-care resources in obesity-hypoventilation syndrome. Chest 2001, 120:377-383.
4. Conti E., Carrozza C., Capoluongo E., Volpe M., Crea F., Zuppi C., Andreotti F. Insulin-like growth factor-1 as a vascular protective factor. Circulation 2004, 110:2260-2265.
5. Friedrich N., Haring R., Nauck M., Ludemann J., Rosskopf D., Spilcke-Liss E., Felix S.B., Dorr M., Brabant G., Volzke H., Wallaschofski H. Mortality and serum insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. J. Clin. Endocrinol. Metab. 2009.
6. Thum T., Hoeber S., Froese S., Klink I., Stichtenoth D.O., Galuppo P., Jakob M., Tsikas D., Anker S.D., Poole-Wilson P.A., Borlak J., Ertl G., Bauersachs J. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ. Res. 2007, 100:434-443.
7. Perticone F., Sciacqua A., Perticone M., Laino I., Miceli S., Care I., Galiano Leone G., Andreozzi F., Maio R., Sesti G. Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. J. Clin. Endocrinol. Metab. 2008, 93:2806-2810.
8. Schini-Kerth V.B. Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells. J. Endocrinol. Invest. 1999, 22:82-88.
9. Sesti G., Sciacqua A., Cardellini M., Marini M.A., Maio R., Vatrano M., Succurro E., Lauro R., Federici M., Perticone F. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 2005, 28:120-125.
10. Sandhu M.S., Heald A.H., Gibson J.M., Cruickshank J.K., Dunger D.B., Wareham N.J. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002, 359:1740-1745.
11. Luboshitzky R., Aviv A., Hefetz A., Herer P., Shen-Orr Z., Lavie L., Lavie P. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J. Clin. Endocrinol. Metab. 2002, 87:3394-3398.
12. Gianotti L., Pivetti S., Lanfranco F., Tassone F., Navone F., Vittori E., Rossetto R., Gauna C., Destefanis S., Grottoli S., De Giorgi R., Gai V., Ghigo E., Maccario M. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J. Clin. Endocrinol. Metab. 2002, 87:5052-5057.
13. Laron Z., Klinger B. Laron syndrome: clinical features, molecular pathology and treatment. Horm. Res. 1994, 42:198-202.
14. 2 response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur. J. Pediatr. 1999, 158:936-940.
15. Lewis M.I., LoRusso T.J., Fournier M. Anabolic influences of insulin-like growth factor I and/or growth hormone on the diaphragm of young rats. J. Appl. Physiol. 1997, 82:1972-1978.
16. Fournier M., Lewis M.I. Influences of IGF-I gene disruption on the cellular profile of the diaphragm. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E707-E715.
17. Lewis M.I., Li H., Huang Z.S., Biring M.S., Cercek B., Fournier M. Influence of varying degrees of malnutrition on IGF-I expression in the rat diaphragm. J. Appl. Physiol. 2003, 95:555-562.
18. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22 (1999) 667-689.
19. Pepin J.L., Delavie N., Pin I., Deschaux C., Argod J., Bost M., Levy P. Pulse transit time improves detection of sleep respiratory events and microarousals in children. Chest 2005, 127:722-730.
20. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. Suppl. 1993, 16:5-40.
21. Read D.J. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann. Med. 1967, 16:20-32.
22. Rajaram S., Baylink D.J., Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 1997, 18:801-831.
23. Leifke E., Gorenoi V., Wichers C., Von Zur Muhlen A., Von Buren E., Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin. Endocrinol. (Oxf) 2000, 53:689-695.
24. Gomez J.M., Maravall F.J., Gomez N., Navarro M.A., Casamitjana R., Soler J. Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin. Endocrinol. (Oxf) 2003, 58:213-219.
25. Eiholzer U., Stutz K., Weinmann C., Torresani T., Molinari L., Prader A. Low insulin IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome. Eur. J. Pediatr. 1998, 157:890-893.
26. Burman P., Ritzen E.M., Lindgren A.C. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr. Rev. 2001, 22:787-799.
27. Livingston F.R., Arens R., Bailey S.L., Keens T.G., Ward S.L. Hypercapnic arousal responses in Prader-Willi syndrome. Chest 1995, 108:1627-1631.
28. Arens R., Gozal D., Omlin K.J., Livingston F.R., Liu J., Keens T.G., Ward S.L. Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. J. Appl. Physiol. 1994, 77:2224-2230.
29. Gozal D., Arens R., Omlin K.J., Ward S.L., Keens T.G. Absent peripheral chemosensitivity in Prader-Willi syndrome. J. Appl. Physiol. 1994, 77:2231-2236.
30. Horn E.M., Waldrop T.G. Modulation of the respiratory responses to hypoxia and hypercapnia by synaptic input onto caudal hypothalamic neurons. Brain Res. 1994, 664:25-33.
31. Hypothalamic Involvement in Respiratory and Cardiovascular Regulation 1995, Dekker, Dempsey JA, Pack AI, New York. J.P. Porter, T.G. Waldrop (Eds.).
32. Grunstein R.R., Ho K.Y., Berthon-Jones M., Stewart D., Sullivan C.E. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am. J. Respir. Crit. Care Med. 1994, 150:496-502.
33. Nass R., Huber R.M., Klauss V., Muller O.A., Schopohl J., Strasburger C.J. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J. Clin. Endocrinol. Metab. 1995, 80:552-557.
34. Lewis M.I., Feinberg A.T., Fournier M. IGF-I and/or growth hormone preserve diaphragm fiber size with moderate malnutrition. J. Appl. Physiol. 1998, 85:189-197.
35. Ameredes B.T., Watchko J.F., Daood M.J., Rosas J.F., Donahoe M.P., Rogers R.M. Growth hormone restores aged diaphragm myosin composition and performance after chronic undernutrition. J. Appl. Physiol. 1999, 87:1253-1259.
36. Fryburg D.A., Gelfand R.A., Barrett E.J. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am. J. Physiol. 1991, 260:E499-E504.
37. Russell-Jones D.L., Weissberger A.J., Bowes S.B., Kelly J.M., Thomason M., Umpleby A.M., Jones R.H., Sonksen P.H. Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy. Acta Endocrinol. (Copenh) 1993, 128(Suppl. 2):44-47.
38. Richelsen B. Effect of growth hormone on adipose tissue and skeletal muscle lipoprotein lipase activity in humans. J. Endocrinol. Invest. 1999, 22:10-15.
39. Bluher S., Kratzsch J., Kiess W. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract. Res. Clin. Endocrinol. Metab. 2005, 19:577-587.
40. Kwiterovich P.O. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am. J. Cardiol. 2000, 86:5L-10L.
41. Jagla A., Schrezenmeir J. Postprandial triglycerides and endothelial function. Exp. Clin. Endocrinol. Diabetes 2001, 109:S533-S547.
42. Silveira A. Postprandial triglycerides and blood coagulation. Exp. Clin. Endocrinol. Diabetes 2001, 109:S527-S532.
43. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am. J. Cardiol. 2000, 86:943-949.
44. Sarwar N., Danesh J., Eiriksdottir G., Sigurdsson G., Wareham N., Bingham S., Boekholdt S.M., Khaw K.T., Gudnason V. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007, 115:450-458.